Annovis Bio, Inc. (ANVS) Insider Trading Disclosures
Annovis Bio, Inc. (ANVS) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ANVS
CIK: 1477845
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerRyan Murray
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-15 | — | SCHEDULE 13G/A Filing | 0000919574-26-006984 | View SEC Doc Filr Page |
| DEFA14A | 2026-10-07 | — | DEFA14A | 0001104659-26-114231 | View SEC Doc Filr Page |
| DEF 14A | 2026-09-11 | 2026-10-14 | DEF 14A | 0001104659-26-107113 | View SEC Doc Filr Page |
| PRE 14A | 2026-08-25 | 2026-08-24 | PRE 14A | 0001104659-26-100460 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001104659-26-097228 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | FORM 8-K | 0001104659-26-097091 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000919574-26-005355 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-29 | — | SCHEDULE 13G Filing | 0000919574-26-004667 | View SEC Doc Filr Page |
| 8-K | 2026-07-10 | 2026-07-07 | FORM 8-K | 0001104659-26-082341 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-17 | FORM 8-K | 0001104659-26-075198 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-20 | OWNERSHIP DOCUMENT | 0001104659-26-065311 | View SEC Doc Filr Page |
| 8-K | 2026-05-20 | 2026-05-20 | FORM 8-K | 0001104659-26-064514 | View SEC Doc Filr Page |
| 424B5 | 2026-05-20 | — | 424B5 | 0001104659-26-064510 | View SEC Doc Filr Page |
| 424B5 | 2026-05-19 | — | 424B5 | 0001104659-26-063959 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001104659-26-062626 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | FORM 8-K | 0001104659-26-062451 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-30 | — | DEFA14A | 0001104659-26-053130 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-06-17 | FORM DEF 14A | 0001104659-26-053096 | View SEC Doc Filr Page |
| 8-K | 2026-04-10 | 2026-04-09 | FORM 8-K | 0001104659-26-041584 | View SEC Doc Filr Page |
| 424B5 | 2026-04-09 | — | 424B5 | 0001104659-26-041561 | View SEC Doc Filr Page |
| 4 | 2026-04-03 | 2026-04-02 | OWNERSHIP DOCUMENT | 0001104659-26-039675 | View SEC Doc Filr Page |
| 144 | 2026-04-02 | — | 144 Filing | 0001972481-26-000128 | View SEC Doc Filr Page |
| 8-K | 2026-03-25 | 2026-03-23 | FORM 8-K | 0001104659-26-034611 | View SEC Doc Filr Page |
| 8-K | 2026-03-16 | 2026-03-16 | FORM 8-K | 0001104659-26-028574 | View SEC Doc Filr Page |
| 10-K | 2026-03-13 | 2025-12-31 | 10-K | 0001104659-26-027751 | View SEC Doc Filr Page |